Rhoen Klinikum AG (WBO:RHK) ROCE %: 4.59% (As of Mar. 2026)


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €14.10
GF Value €13.49
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG ROCE %?

Rhoen Klinikum AG WBO:RHK +0.71% 74 ROCE % is 4.59% as of Mar. 2026. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.49. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rhoen Klinikum AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.59%.

Rhoen Klinikum AG  (WBO:RHK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rhoen Klinikum AG ROCE % Related Terms

Rhoen Klinikum AG ROCE % Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG ROCE % Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 2.69 3.61 4.13 3.29

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 3.02 3.25 4.15 4.59
WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG ROCE % Calculation

Rhoen Klinikum AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=48.15/( ( (1856.67 - 404.853) + (1819.176 - 341.828) )/ 2 )
=48.15/( (1451.817+1477.348)/ 2 )
=48.15/1464.5825
=3.29 %

Rhoen Klinikum AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=68.024/( ( (1819.176 - 341.828) + (1841.057 - 355.558) )/ 2 )
=68.024/( ( 1477.348 + 1485.499 )/ 2 )
=68.024/1481.4235
=4.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.59% mean?
Rhoen Klinikum AG (WBO:RHK) has a ROCE % of 4.59% as of Mar. 2026.
Is Rhoen Klinikum AG's ROCE % too high?
Rhoen Klinikum AG's current ROCE % is 4.59%. The Healthcare Providers & Services industry median ROCE % is 6.41. Rhoen Klinikum AG's value of 4.59% is 28.4% below this industry median. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's ROCE % compare to HCA and THC?
Rhoen Klinikum AG's ROCE % of 4.59% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Rhoen Klinikum AG's value of 4.59% is 28.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current ROCE % of 4.59% is 28.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current ROCE % is 4.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current ROCE % of 4.59%. The stock's GF Value™ is €13.49, compared to a current price of €14.10 — trading 4.5% above its estimated fair value. The current ROCE % is 4.59% and 28.4% below the Healthcare Providers & Services industry median of 6.41. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current ROCE % is 4.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.10 is trading 4.5% above its estimated GF Value™ of €13.49.

Key valuation signals for WBO:RHK:

  • ROCE %: 4.59%
  • GF Value™: €13.49 vs. price of €14.10 (4.5% above fair value)
  • GF Score™: 74/100 with 3 warning signs
  • Industry Position: 28.4% below the Healthcare Providers & Services median

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€13.49
GF Value